The consumer-genomics company 23andMe just sold its biobank of customer genetic data to drugmaker Regeneron for $256 million.

The pharmaceutical giant plans to continue offering 23andMe’s DNA testing service and pledged to adopt its privacy practices ...

After acquiring 23andMe, Regeneron Pharmaceuticals has said it will protect user data as it uses DNA data for drug ...

Scientists are probing woolly mammoth and Neanderthal genetic codes for new compounds as today’s drugs lose potency.

DNA is the genetic code that provides the biological instructions for every living species, but not every bit of DNA helps ...

Rapidly mutating DNA regions were mapped using a multi-generational family and advanced sequencing tools. Understanding how ...

Pharmaceutical giant Regeneron has promised to prioritise the “ethical use” of the sequenced DNA data of more than 15 million ...

issued a statement emphasizing the drugmaker's "deep experience with large-scale data management, having worked with collaborators around the world to link deidentified DNA sequences from nearly ...

Mounting evidence from genome studies indicates that, contrary to received wisdom, our species has undergone profound ...

Regeneron Pharmaceuticals said it will acquire 23andMe's business. What happened to 23andMe? Should you delete your data?

Have you ever dreamed of being a mushroom scientist? Now is your chance. The New Brunswick Museum is starting a citizen ...

Alicella gigantea, a rarely sighted giant crustacean that inhabits the depths of the ocean and can reach up to 34 cm in ...